Explore Business Standard
Neurological Disorders
Having a neurodevelopmental condition such as autism and ADHD could be related with a nearly five times higher chance of dying before age 25, compared to those without, according to a study conducted in New Zealand. While relative risk between the two groups is high, it is important to remember that deaths in this group remain rare, said lead author Nick Bowden, from the University of Otago's department of paediatrics and child health. Symptoms of neurodevelopmental conditions can emerge in early childhood, impairing one's development in skills such as language, communication or behaviour. Social communication and behaviour is affected in autism, while ability to pay attention and focus on a task and emotion regulation is impaired in attention deficit hyperactivity disorder (ADHD). Using the StatsNZ database, the researchers followed nearly nine lakh children born between 1995 and 2009 until 2019. About 40,000 (4.5 per cent) of the total had a neurodevelopmental condition, identif
A rapid reform to healthcare systems, public policy and attitude in society would be required to address burden of Alzheimer's disease in population, even as medications and blood tests present a potential in diagnosis and treatment, researchers say in a Lancet Series. Alzheimer's disease -- the most common form of dementia -- is an ageing-related neurological disorder which steadily impacts one's memory and thought processes, eventually interfering with daily activities. Describing new treatments and diagnostic methods for the condition in a series of three papers in The Lancet journal, the international team of researchers said that medications -- lecanemab and donanemab -- could slow down Alzheimer's disease from advancing. The drugs, which target specific proteins in a cell, have shown an efficacy comparable to that of drugs for cancer and autoimmune disorders such as rheumatoid arthritis and multiple sclerosis, the team said. They added that however, high costs of medicines, .
The tally of suspected and confirmed Guillain-Barre Syndrome (GBS) cases in the Pune region has reached 197 with the detection of five more patients of the rare nerve disorder, health department officials said on Tuesday. The five patients in Pune comprised two fresh cases and three from previous days, an official from the health department said. "Of the 197 cases, 172 have been diagnosed with GBS. At least 40 patients are from Pune Municipal Corporation areas, 92 from newly added villages in the PMC, 29 from the Pimpri Chinchwad civic limits, 28 from Pune Rural and eight from other districts. While 104 patients have been discharged, 50 are in ICU and 20 on ventilator support," a health department release said. The number of deaths suspected to have been caused by GBS in the region stood unchanged at seven, it added. GBS is a rare condition in which a person's immune system attacks the peripheral nerves, resulting in muscle weakness, loss of sensation in the legs and/or arms, as ..
The tally of suspected Guillain-Barr syndrome (GBS) cases in the Pune region has reached 180, with the detection of seven cases, while a 64-year-old woman became the first patient diagnosed with the nerve disorder in Mumbai, officials said. The seven cases in Pune comprise four fresh cases and three from previous days, an official from the health department said on Friday. "Of the 180 suspected cases, 146 have been diagnosed with GBS. At least 35 patients are from Pune Municipal Corporation, 88 from newly added villages in the PMC area, 25 from the Pimpri Chinchwad civic limits, 24 from Pune Rural and eight from other districts. While 79 patients have been discharged, 58 are in ICU and 22 on ventilator support," a health department release said. The number of deaths in the region stood at six, it added. Mumbai reported its first case of GBS on Friday after a 64-year-old woman was diagnosed with the rare nerve disorder, civic officials said. Talking to PTI, Brihanmumbai Municipal .
Neurological conditions such as epilepsy, Alzheimer's disease and dementia are now the leading cause of ill health and disability globally, affecting 3.4 billion people in 2021, according to a major new analysis published in The Lancet Neurology journal. Globally, the number of people living with, or dying from, neurological conditions such as stroke, Alzheimer's disease and other dementias, and meningitis has risen substantially over the past 30 years. This is due to the growth and ageing of the global population as well as increased exposure to environmental, metabolic, and lifestyle risk factors, the researchers said. The study suggests that worldwide, the overall amount of disability, illness, and premature death -- a measurement known as disability-adjusted life years (DALYs) -- caused by neurological conditions increased by 18 per cent over the past 31 years, rising from around 375 million years of healthy life lost in 1990 to 443 million years in 2021. The analysis from the .